Skip to content

Boston Scientific BSX Investing Cash Flow

Investing Cash Flow at other companies

Abbott logo
AbbottABT
-$20.32B-4,224%
TFX
TeleflexTFX
-$74.79M-160%
Johnson & Johnson logo
Johnson & JohnsonJNJ
-$1.04B-250%
Stryker logo
StrykerSYK
-$185M+95.5%
Haemonetics logo
HaemoneticsHAE
-$86.61M
CONMED logo
CONMEDCNMD
$4.11M+240%

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$63.44B-56.6%
P/E17.8×-40.8×
P/S3.1×-4.8×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's investing cash flow?
Boston Scientific (BSX) reported investing cash flow of -$591M in Q1 2026.
How has Boston Scientific's investing cash flow changed year-over-year?
Boston Scientific's investing cash flow decreased by 18.2% year-over-year, from -$500M to -$591M.
What is the long-term trend for Boston Scientific's investing cash flow?
Over 4 years (2021 to 2025), Boston Scientific's investing cash flow has grown at a 13.4% compound annual growth rate (CAGR), from -$1.6B to -$2.64B.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.